Although when CXCR3 is expressed by tumor cells its ligands may promote tumor growth (16, 135–137), many studies demonstrated that these chemokines exert immuno-angiostatic activities on the TME (16, 138, 139). This evidence concerns the gene CXCR3 and neoplasm.